JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.
Vicente
C
C
Vázquez
I
I
Marcotegui
N
N
Conchillo
A
A
Carranza
C
C
Rivell
G
G
Bandrés
E
E
Cristobal
I
I
Lahortiga
I
I
Calasanz
M J
MJ
Odero
M D
MD
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D005819:Genetic Markers; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics* / Q000502:physiology*; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008957:Models, Genetic; D009154:Mutation; D011379:Prognosis; D012306:Risk; D013997:Time Factors
D005819:Genetic Markers; D053614:Janus Kinase 2